Multi-dimensional Fragmentomic Assay for Early Detection of Pancreatic Neuroendocrine Tumors

RecruitingOBSERVATIONAL

Enrollment

440

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Pancreatic Neuroendocrine Tumor

Interventions

DIAGNOSTIC_TEST

Blood collection

Blood collection for fragmentomic profiles of plasma cell-free DNA

Trial Locations (1)

RECRUITING

Fudan University shanghai cancer center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER